Results 281 to 290 of about 335,942 (340)

The Global Prevalence of Antibiotic Resistance and Shiga Toxin-Producing <i>Escherichia coli</i> in Chickens: A Systematic Review and Meta-Analysis (2011-2024). [PDF]

Antibiotics (Basel)
Ramatla T, Jane N, Dineo M, Mpho T, Tshegofatso M, Khasapane NG.   +5 more
europepmc   +1 more source

Inhibition of tumour necrosis factor alpha by Etanercept attenuates Shiga toxin-induced brain pathology. [PDF]

J Neuroinflammation
Christ R, Siemes D, Zhao S, Widera L, Spangenberg P, Lill J, Thiebes S, Bottek J, Borgards L, Pinho AG, Silva NA, Monteiro S, Jorch SK, Gunzer M, Siebels B, Voss H, Schlüter H, Shevchuk O, Chen J, Engel DR.   +19 more
europepmc   +1 more source

Co-resistance and plasmid-mediated co-dissemination of florfenicol and azithromycin resistance in non-O157 Shiga toxin-producing Escherichia coli from cattle in Xinjiang, China. [PDF]

BMC Microbiol
Wang L, Lan X, Bai Y, Huang Y, Jin W, Zhang M, Zheng X, Zhang Y, Du X, Liu Y, Ma X, Geng M, Su Z, Xie J, Tong P.   +14 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Nanobody-Based Bispecific Neutralizer for Shiga Toxin-Producing E. coli.

ACS Infectious Diseases, 2022
Currently, no specific therapeutics are available for foodborne Shiga toxin-producing Escherichia coli (STEC) infections that cause severe gastroenteritis and life-threatening complications of hemolytic uremic syndrome (HUS).
Zhongkai Lu, Zhicheng Liu, Xia Li, Xinfang Qin, Haofei Hong, Zhifang Zhou, R. Pieters, Jie Shi, Zhimeng Wu   +8 more
semanticscholar   +1 more source

Shiga Toxin-Producing Escherichia coli Transmission via Fecal Microbiota Transplant.

Clinical Infectious Diseases, 2020
Fecal microbiota transplantation (FMT) is recommended therapy for multiply recurrent Clostridioides difficile infection. We report adverse events in 7 patients who received FMT from a stool donor who was colonized with Shiga toxin-producing Escherichia ...
Caroline Zellmer, M. Sater, Miriam H. Huntley, M. Osman, S. Olesen, Bharat Ramakrishna   +5 more
semanticscholar   +1 more source

Shiga toxins

Toxicon, 2012
Shiga toxins are virulence factors produced by the bacteria Shigella dysenteriae and certain strains of Escherichia coli. There is currently no available treatment for disease caused by these toxin-producing bacteria, and understanding the biology of the Shiga toxins might be instrumental in addressing this issue.
Jonas, Bergan, Anne Berit, Dyve Lingelem, Roger, Simm, Tore, Skotland, Kirsten, Sandvig   +4 more
openaire   +2 more sources

Shiga toxin E. coli

Encyclopedia of Gastroenterology, 2020
L. Holtz, S. Grisaru, P. Tarr
semanticscholar   +2 more sources

Effect of Shiga toxin and Shiga-like toxins on eukaryotic cells

Microbes and Infection, 2001
Shigella dysenteriae and Shiga-toxin-producing Escherichia coli (STEC) elaborate the AB holotoxins, Shiga or Shiga-like toxins (Stx). Stx play a major role in the pathogenesis of haemorrhagic colitis and haemolytic uremic syndrome. This review provides an overview of the mechanisms of action of Stx and a model of the pathogenesis of Stx-induced disease.
E V, O'Loughlin, R M, Robins-Browne
openaire   +2 more sources

Shiga toxins

Toxicon, 2001
Shiga toxin and Shiga-like toxins belong to the group of protein toxins which have a moiety that binds to the cell surface and another enzymatically active moiety that after entry into the cytosol inhibits protein synthesis enzymatically. The toxins can also cause apoptosis by mechanisms that may be different from the effect on the protein synthesis ...
openaire   +2 more sources